| SLE | systemic lupus erythematosus |
| T1D | type 1 diabetes |
| MS | multiple sclerosis |
| RA | rheumatoid arthritis |
| BCR | B cell receptor |
| tNPs | tolerogenic nanoparticles |
| APC | antigen-presenting cell |
| MHC | major histocompatibility complex |
| EAE | experimental autoimmune encephalomyelitis |
| FVIII | Factor VIII |
| CAR | chimeric antigen receptor |
| ITAM | immunoreceptor tyrosine-based activation motif |
| PV | pemphigus vulgaris |
| Dsg3 | desmoglein 3 |
| NOD | non-obese diabetic |
| BAR | B-cell-targeting Antibody Receptor |
| CAAR | chimeric auto-antibody receptor |
| Treg | T regulatory cell |
| Teff | T effector cell |
| NK | natural killer cell |
| ADCC | antibody-dependent cell-mediated cytotoxicity |
| ADC | antibody-drug conjugate |